Find a Specialist by Postal Code | Page 4 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Find a Specialist by Postal Code

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Name Institution City State Country Disease Expertise
Robert Collins, MD Harold C. Simmons Comprehensive Cancer Center Dallas Texas United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Madhuri Vusirikala, MD Harold C. Simmons Comprehensive Cancer Center Dallas Texas United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Regis Peffault de Latour, MD, PhD Hôpital Saint-Louis Paris Paris (75) France
  • Aplastic Anemia
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Marie Sebert, MD, PhD Hôpital Saint-Louis Paris Paris (75) France
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Roberto Ovilla Martinez, MD Hospital Angeles Lomas Huixquilucan Mexico
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Rodrigo Calado, MD, PhD Hospital das Clínicas de Ribeirão Preto Ribeirão Preto São Paulo Brazil
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Daria Babushok, MD, PhD Hospital of the University of Pennsylvania Philadelphia Pennsylvania United States
  • Aplastic Anemia
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Carmem Bonfim, MD, PhD Hospital Pequeno Principe and Hospital de Clinicas - Federal University of Parana Água Verde, Curitiba Paraná Brazil
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
Phil Scheinberg, MD Hospital Sao Jose, Beneficencia Portuguesa de Sao Paolo Sao Paulo Brazil
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Lawrence Rice, MD Houston Methodist Hospital Houston Texas United States
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Catherine J. Lee, MD Huntsman Cancer Center, University of Utah Salt Lake City Utah United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Srinivas Tantravahi, MBBS, MRCP Huntsman Cancer Hospital Salt Lake City Utah United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Luca Malcovati, MD IRCCS S. Matteo Hospital Foundation & University of Pavia Pavia Pavia Italy
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Stephan Paul, MD, JD J. W. Ruby Memorial Hospital Morgantown West Virginia United States
  • Acute Myeloid Leukemia (AML)
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Myelodysplastic Syndromes (MDS)
  • Pediatric
Ivana Gojo Johns Hopkins Medicine Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Mark Levis, MD, PhD Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
Mary Armanios, MD Johns Hopkins University Baltimore Maryland United States
Veronica Dioverti, MD Johns Hopkins University School of Medicine Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Suresh Balasubramanian Karmanos Cancer Institute Detroit Michigan United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pure Red Cell Aplasia (PRCA)
Suresh Balasubramian, MD Karmanos Cancer Institute Detroit Michigan United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)